BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Delfi M, Sartorius R, Ashrafizadeh M, Sharifi E, Zhang Y, De Berardinis P, Zarrabi A, Varma RS, Tay FR, Smith BR, Makvandi P. Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today 2021;38:101119. [PMID: 34267794 DOI: 10.1016/j.nantod.2021.101119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Advances in Colloid and Interface Science 2022. [DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
2 Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, Far FB, Sharifzadeh SO, Samarghandian S, Khan H, Aref AR, Ashrafizadeh M, Zarrabi A, Sethi G. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacol Res 2021;171:105759. [PMID: 34245864 DOI: 10.1016/j.phrs.2021.105759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ye Z, Liang L, Lu H, Shen Y, Zhou W, Li Y. Nanotechnology-Employed Bacteria-Based Delivery Strategy for Enhanced Anticancer Therapy. Int J Nanomedicine 2021;16:8069-86. [PMID: 34934313 DOI: 10.2147/IJN.S329855] [Reference Citation Analysis]
4 Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Zabolian A, Hashemi M, Hushmandi K, Ashrafizadeh M, Aref AR, Samarghandian S. Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies. Biomed Pharmacother 2021;144:112335. [PMID: 34700233 DOI: 10.1016/j.biopha.2021.112335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Akbarzadeh I, Farid M, Javidfar M, Zabet N, Shokoohian B, Arki MK, Shpichka A, Noorbazargan H, Aghdaei HA, Hossein-Khannazer N, Timashev P, Makvandi P, Vosough M. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells. AAPS PharmSciTech 2022;23:57. [PMID: 35048234 DOI: 10.1208/s12249-022-02212-0] [Reference Citation Analysis]
6 Yang J, Zheng R, Mamuti M, Hou D, Zhao Y, An H, Wang H, Zhao Y. Oncolytic peptide nanomachine circumvents chemo resistance of renal cell carcinoma. Biomaterials 2022;284:121488. [DOI: 10.1016/j.biomaterials.2022.121488] [Reference Citation Analysis]
7 Liu J, Li Y, Zhang H, Liu S, Yang M, Cui M, Zhang T, Yu Y, Xiao H, Du Z. Fabrication, characterization and functional attributes of zein-egg white derived peptides (EWDP)-chitosan ternary nanoparticles for encapsulation of curcumin: Role of EWDP. Food Chem 2022;372:131266. [PMID: 34628117 DOI: 10.1016/j.foodchem.2021.131266] [Reference Citation Analysis]
8 Mojarad-Jabali S, Farshbaf M, Hemmati S, Sarfraz M, Motasadizadeh H, Shahbazi Mojarrad J, Atyabi F, Zakeri-Milani P, Valizadeh H. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Int J Pharm 2021;613:121395. [PMID: 34933080 DOI: 10.1016/j.ijpharm.2021.121395] [Reference Citation Analysis]
9 Paskeh MDA, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, Saleki H, Sharifzadeh SO, Far FB, Ashrafizadeh M, Samarghandian S, Khan H, Ghavami S, Zarrabi A, Łos MJ. Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166326. [DOI: 10.1016/j.bbadis.2021.166326] [Reference Citation Analysis]
10 Zafar A, Hasan M, Tariq T, Dai Z. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies. Bioconjug Chem 2021. [PMID: 34793138 DOI: 10.1021/acs.bioconjchem.1c00437] [Reference Citation Analysis]
11 Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Thakur Kumar V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistance. Expert Opin Drug Deliv 2022. [PMID: 35152815 DOI: 10.1080/17425247.2022.2041598] [Reference Citation Analysis]
12 Yazdani H, Shahbazi MA, Varma RS. 2D and 3D Covalent Organic Frameworks: Cutting-Edge Applications in Biomedical Sciences. ACS Appl Bio Mater 2022;5:40-58. [PMID: 35014828 DOI: 10.1021/acsabm.1c01015] [Reference Citation Analysis]
13 Mani S, Swargiary G, Tyagi S, Singh M, Jha NK, Singh KK. Nanotherapeutic approaches to target mitochondria in cancer. Life Sci 2021;281:119773. [PMID: 34192595 DOI: 10.1016/j.lfs.2021.119773] [Reference Citation Analysis]
14 Shi L, Kuang D, Ma X, Jalalah M, Alsareii SA, Gao T, Harraz FA, Yang J, Li G. Peptide Assembled in a Nano-confined Space as a Molecular Rectifier for the Availability of Ionic Current Modulation. Nano Lett 2022. [PMID: 35049303 DOI: 10.1021/acs.nanolett.1c04154] [Reference Citation Analysis]
15 Fu L, Zhang J, Wu C, Wang W, Wang D, Hu Z, Wang Z. A novel PD-L1 targeting peptide self-assembled nanofibers for sensitive tumor imaging and photothermal immunotherapy in vivo. Nano Res . [DOI: 10.1007/s12274-022-4331-5] [Reference Citation Analysis]
16 Ashrafizadeh M, Zarrabi A, Mirzaei S, Hashemi F, Samarghandian S, Zabolian A, Hushmandi K, Ang HL, Sethi G, Kumar AP, Ahn KS, Nabavi N, Khan H, Makvandi P, Varma RS. Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery. Food Chem Toxicol 2021;157:112576. [PMID: 34571052 DOI: 10.1016/j.fct.2021.112576] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Moammeri A, Abbaspour K, Zafarian A, Jamshidifar E, Motasadizadeh H, Dabbagh Moghaddam F, Salehi Z, Makvandi P, Dinarvand R. pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Tumorigenesis Breast Cancer. ACS Appl Bio Mater 2022. [PMID: 35129960 DOI: 10.1021/acsabm.1c01107] [Reference Citation Analysis]
18 Jahangiri-manesh A, Mousazadeh M, Taji S, Bahmani A, Zarepour A, Zarrabi A, Sharifi E, Azimzadeh M. Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements. Pharmaceutics 2022;14:664. [DOI: 10.3390/pharmaceutics14030664] [Reference Citation Analysis]
19 Sharifi E, Bigham A, Yousefiasl S, Trovato M, Ghomi M, Esmaeili Y, Samadi P, Zarrabi A, Ashrafizadeh M, Sharifi S, Sartorius R, Dabbagh Moghaddam F, Maleki A, Song H, Agarwal T, Maiti TK, Nikfarjam N, Burvill C, Mattoli V, Raucci MG, Zheng K, Boccaccini AR, Ambrosio L, Makvandi P. Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation. Adv Sci (Weinh) 2021;:e2102678. [PMID: 34796680 DOI: 10.1002/advs.202102678] [Reference Citation Analysis]
20 He X, Yang L, Su H, Lin S, Qi D, Chen H, Qu Y, Liu L, Feng X. Clickable amino acid derivative tuned self-assembly of antigen and adjuvant for cancer immunotherapy. J Control Release 2021;337:306-16. [PMID: 34311025 DOI: 10.1016/j.jconrel.2021.07.033] [Reference Citation Analysis]
21 Bu ZQ, Yao QF, Liu QY, Quan MX, Lu JY, Huang WT. Peptide-Based Sensing, Logic Computing, and Information Security on the Antimonene Platform. ACS Appl Mater Interfaces 2022. [PMID: 35112857 DOI: 10.1021/acsami.1c23814] [Reference Citation Analysis]